Optimind Pharma Corp.
OMND
CNSX
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, January 29, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Jun 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
647-891-9379
Address
77 King Street West
Toronto, ON M5K 1G8
Toronto, ON M5K 1G8
Country
Year Founded
--
Business Description
Sector
Industry
Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other...
more
